University of Catania

A nasal spray targeting the enzyme zDHHC7 may treat Alzheimer’s by reducing cognitive decline and harmful protein accumulation, according to Italian researchers. Funded by a €890,000 grant, the study in mice showed reduced beta-amyloid and extended lifespan with the spray, highlighting zDHHC7 as a therapeutic target.